Addition of a disclaimer to a claim, based on words not present in the application as filed, is referred to as an undisclosed disclaimer.
Judy M. Mohr, PhD
Advertisement
Perkins Coie, LLP
Articles by Judy M. Mohr, PhD
The courts regard biotechnology as highly unpredictable
Only the product that served as the basis of the extension is exclusively covered by the patent during its extended term.
Advertisement
Latest Updated Articles
- IP Briefs: The Positive Side of Negative Disclaimers
Published: June 1st 2007 | Updated:
Legal Forum: Literal Claim Scope and After-Arising TechnologiesPublished: July 1st 2006 | Updated:
Legal Forum: Drug Product, Active Ingredient, and Patent Term: A Recipe for ConfusionPublished: May 1st 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
